Both AD and CD inhibited LAG3 expression in vitro, indicating the possible pathways of AD/ADAM10/LAG3 or CD/ADAM10/LAG3 in anti-cancers, or suggesting a potential method for immunotherapy of cancers. Here, CTLA4 is linked to cancer.